Creation of a Marine Natural Products Library to Enhance Life Science Research
创建海洋天然产物库以加强生命科学研究
基本信息
- 批准号:7934694
- 负责人:
- 金额:$ 58.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2012-09-29
- 项目状态:已结题
- 来源:
- 关键词:AdvertisingAgreementAlzheimer&aposs DiseaseAnti-Bacterial AgentsAntimalarialsAntineoplastic AgentsAutomationBiochemicalBiologicalBiological FactorsBiological SciencesChemicalsCollaborationsCollectionCommunicable DiseasesCommunitiesCompanionsContractsDatabasesDiabetes MellitusDiseaseDiversity LibraryEquipmentFractionationFreezingFundingGenerationsGoalsHigh Pressure Liquid ChromatographyHistone Deacetylase InhibitorHumanI Kappa B-AlphaIndustryInstitutesLaboratoriesLeadLibrariesLiquid ChromatographyLiquid substanceMalariaMalignant NeoplasmsManufacturer NameMarinesMeasurableMedicineMethodsNatural Products ChemistryNatureOccupationsOrganismOutcomePharmaceutical PreparationsProcessProductionProteomeResearchResearch InfrastructureResearch Project GrantsResearch SupportResourcesRoboticsScreening procedureSourceSpecimenStreamStructureStudentsSystemTherapeutic AgentsTrainingWaterdata miningdrug developmentdrug discoveryfollow-upgraduate studenthigh schoolhigh throughput screeninginhibitor/antagonistmarine natural productmarine organismmaterial transfer agreementmeetingsmicrobialnovelnovel therapeuticspostdoctoral investigatorpressureprogramspublic health relevancerepositoryscaffoldsmall molecule librariestoolweb page
项目摘要
DESCRIPTION (provided by applicant): Natural products represent an excellent source of novel chemical scaffolds that are inherently biologically active. It has been estimated that 78% of the 90 antibacterial agents and 62% of the 79 anticancer agents approved for use in the US over the past two decades have their origins in natural products. With advances in robotics, High Throughput Screening (HTS) has become the primary approach used worldwide to discover new lead compounds for drug development and chemical probes to better understand the disease process. Unfortunately, natural products extracts are not readily amenable for use in discovery programs that use HTS which has led to a significant reduction in opportunities for new drug and chemical probe discovery. The current proposal seeks to overcome this obstacle by creating a unique library of marine natural products (both enriched fractions and purified compounds) that is compatible with HTS and is available to the Life Sciences Research Community as a new research tool. In this two year project we seek to create a unique library of marine natural products, designated as the Harbor Branch Oceanographic Institute (HBOI) Marine Natural Product Library (MNPL), which will serve as a long term resource to the scientific community. HBOI has been engaged in the production of such a library for the past five years as part of a National Cooperative Drug Discovery Project and has successfully created a library from approximately 150 organisms. Screening of the existing chemical library has allowed for the rapid discovery of many new structures including novel histone deacetylase inhibitors, MCL-1 inhibitors, anti-malarial agents and inhibitors of nuclear factor kappa B. HBOI has a repository of over 14,000 frozen marine specimens and 19,000 marine microbial isolates that could be used in generation of an expanded Marine Natural Products Library. In the current proposal we seek to greatly expand the diversity of the library through adding automation to the fractionation process and hiring new graduates and students to conduct chemical fractionation on 750-1250 organisms found in the HBOI Frozen Organism Repository and 250-350 organisms from the Marine Microbial Culture Collection. The library will be made available to external collaborators through material transfer agreements, collaborative research agreements and sponsored research projects.
Public Health Relevance: This project will create a unique resource - the HBOI Marine Natural Products Library- for the discovery of biological probes and new medicines. This resource will be a library of pure and enriched fractions derived from marine organisms that will be available for screening by the High Through put Screening Community. Such a library will provide access to unique chemical diversity to enhance the US Life Science Research Enterprise.
描述(申请人提供):天然产品是具有生物活性的新型化学支架的极好来源。据估计,在过去20年里,在美国批准使用的90种抗菌剂中,78%的抗菌剂和79种抗癌剂中的62%来自天然产品。随着机器人技术的进步,高通量筛选(HTS)已成为全球范围内发现新的先导化合物用于药物开发和化学探针以更好地了解疾病过程的主要方法。不幸的是,天然产品提取物不容易用于使用HTS的发现计划,这导致发现新药和化学探针的机会大大减少。目前的提案试图通过创建一个独特的海洋天然产物(包括浓缩部分和纯化化合物)库来克服这一障碍,该库与HTS兼容,并可作为新的研究工具提供给生命科学研究社区。在这个为期两年的项目中,我们试图创建一个独特的海洋天然产品图书馆,命名为海港分部海洋研究所(HBOI)海洋天然产品图书馆(MNPL),它将作为科学界的长期资源。作为国家合作药物发现项目的一部分,HBOI在过去五年中一直致力于制作这样一个库,并成功地用大约150个生物体创建了一个库。通过对现有化学库的筛选,可以迅速发现许多新的结构,包括新型组蛋白脱乙酰酶抑制剂、MCL-1抑制剂、抗疟疾药物和核因子kappa B抑制剂。HBOI拥有超过14,000个冷冻海洋标本和19,000个海洋微生物分离株,可用于建立一个扩大的海洋天然产物库。在目前的提案中,我们试图通过增加分馏过程的自动化,并聘请新的毕业生和学生对HBOI冷冻生物库中的750-1250个生物和海洋微生物培养库中的250-350个生物进行化学分选,从而极大地扩大图书馆的多样性。图书馆将通过材料转让协议、合作研究协议和赞助研究项目向外部合作者开放。
公共卫生相关性:该项目将创建一个独特的资源--HBOI海洋天然产品图书馆--用于发现生物探针和新药。这个资源将是一个从海洋生物中提取的纯净和浓缩的级分的库,将可供High Throught Screen社区进行筛查。这样的图书馆将提供获取独特化学多样性的途径,以加强美国生命科学研究企业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AMY Elizabeth WRIGHT其他文献
AMY Elizabeth WRIGHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AMY Elizabeth WRIGHT', 18)}}的其他基金
Discovery of Marine Invertebrate-Derived Antimalarial Agents
海洋无脊椎动物来源的抗疟药物的发现
- 批准号:
8583125 - 财政年份:2013
- 资助金额:
$ 58.07万 - 项目类别:
Production of Pilot Scale Libraries of Marine Natural Products
海洋天然产物中试规模库的生产
- 批准号:
7758447 - 财政年份:2010
- 资助金额:
$ 58.07万 - 项目类别:
Production of Pilot Scale Libraries of Marine Natural Products
海洋天然产物中试规模库的生产
- 批准号:
8247697 - 财政年份:2010
- 资助金额:
$ 58.07万 - 项目类别:
Production of Pilot Scale Libraries of Marine Natural Products
海洋天然产物中试规模库的生产
- 批准号:
8056125 - 财政年份:2010
- 资助金额:
$ 58.07万 - 项目类别:
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
发现有效对抗胰腺癌的新型抗肿瘤药物
- 批准号:
7914808 - 财政年份:2009
- 资助金额:
$ 58.07万 - 项目类别:
Creation of a Marine Natural Products Library to Enhance Life Science Research
创建海洋天然产物库以加强生命科学研究
- 批准号:
7861971 - 财政年份:2009
- 资助金额:
$ 58.07万 - 项目类别:
New Anticancer Agents from Atlantic and Caribbean
来自大西洋和加勒比海的新型抗癌剂
- 批准号:
6924486 - 财政年份:2005
- 资助金额:
$ 58.07万 - 项目类别:
ANTITUMOR AGENTS EFFECTIVE AGAINST PANCREATIC CANCER
有效对抗胰腺癌的抗肿瘤药物
- 批准号:
7626984 - 财政年份:2003
- 资助金额:
$ 58.07万 - 项目类别:
ANTITUMOR AGENTS EFFECTIVE AGAINST PANCREATIC CANCER
有效对抗胰腺癌的抗肿瘤药物
- 批准号:
6572826 - 财政年份:2003
- 资助金额:
$ 58.07万 - 项目类别:
Discovery of Novel Antitumor Agents Effective Against Pancreatic Cancer
发现有效对抗胰腺癌的新型抗肿瘤药物
- 批准号:
8090437 - 财政年份:2003
- 资助金额:
$ 58.07万 - 项目类别:
相似海外基金
A study for cross borders Indonesian nurses and care workers: Case of Japan-Indonesia Economic Partnership Agreement
针对跨境印度尼西亚护士和护理人员的研究:日本-印度尼西亚经济伙伴关系协定的案例
- 批准号:
22KJ0334 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Grant-in-Aid for JSPS Fellows
NSF-NOAA Interagency Agreement (IAA) for the Global Oscillations Network Group (GONG)
NSF-NOAA 全球振荡网络组 (GONG) 机构间协议 (IAA)
- 批准号:
2410236 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Cooperative Agreement
Conditions for U.S. Agreement on the Closure of Contested Overseas Bases: Relations of Threat, Alliance and Base Alternatives
美国关于关闭有争议的海外基地协议的条件:威胁、联盟和基地替代方案的关系
- 批准号:
23K18762 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
MSI Smart Manufacturing Data Hub – Open Calls Grant Funding Agreement
MSI 智能制造数据中心 – 公开征集赠款资助协议
- 批准号:
900240 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Collaborative R&D
Challenges of the Paris Agreement Exposed by the Energy Shift by External Factors: The Case of Renewable Energy Policies in Japan, the U.S., and the EU
外部因素导致的能源转移对《巴黎协定》的挑战:以日本、美国和欧盟的可再生能源政策为例
- 批准号:
23H00770 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Continuation of Cooperative Agreement between U.S. Food and Drug Administration and S.C. Department of Health and Environmental Control (DHEC) for MFRPS Maintenance.
美国食品和药物管理局与南卡罗来纳州健康与环境控制部 (DHEC) 继续签订 MFRPS 维护合作协议。
- 批准号:
10829529 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
National Ecological Observatory Network Governing Cooperative Agreement
国家生态观测站网络治理合作协议
- 批准号:
2346114 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Cooperative Agreement
The Kansas Department of Agriculture's Flexible Funding Model Cooperative Agreement for MFRPS Maintenance, FPTF, and Special Project.
堪萨斯州农业部针对 MFRPS 维护、FPTF 和特别项目的灵活资助模式合作协议。
- 批准号:
10828588 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Robust approaches for the analysis of agreement between clinical measurements: development of guidance and software tools for researchers
分析临床测量之间一致性的稳健方法:为研究人员开发指南和软件工具
- 批准号:
MR/X029301/1 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Linguistic transfer in a contact variety of Spanish: Gender agreement production and attitudes
博士论文研究:西班牙语接触变体中的语言迁移:性别协议的产生和态度
- 批准号:
2234506 - 财政年份:2023
- 资助金额:
$ 58.07万 - 项目类别:
Standard Grant